Literature DB >> 30569180

The HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced protective autophagy in glioblastoma and astrocytoma.

Sihua Huang1, Peng Qi2, Ting Zhang1, Fengtao Li1, Xijing He1.   

Abstract

Human glioblastoma is a malignant and aggressive primary human brain solid tumor characterized by severe hypoxia. Hypoxia can induce autophagy, which may result in chemoresistance and malignant progression of cancer cells. MicroRNAs (miRNAs) have been reported to modulate hypoxia‑induced autophagy in various types of cancers. In the present study, we observed that hypoxia‑inducible factor (HIF)‑1α expression was increased while miR‑224‑3p expression was decreased under hypoxia in a time‑dependent manner in glioma LN229 and astrocytoma U‑251MG cell lines, as deteced by western blot analysis and real‑time quantitative polymerase chain reaction. In addition, HIF‑1α knockout inhibited cell motility and chemosensitivity by negatively regulating the expression of miR‑224‑3p under a hypoxic condition by Transwell and MTT assay. Moreover, hypoxia increased the relative expression of ATG5 (autophagy‑related gene 5) and LC3 II/I with a decreased level of p62. These results were correlated with autophagy in a time‑dependent manner, suggesting that hypoxia induced autophagy in glioblastoma and astrocytoma cells. Through bioinformatic prediction and luciferase reporter assay, we confirmed that ATG5 is a target of miR‑224‑3p and ATG5 expression was negatively regulated by miR‑224‑3p. Knockdown of ATG5 inhibited cell mobility with increased chemosensitivity of glioblastoma cells under hypoxia. Moreover, overexpression of miR‑224‑3p also inhibited cell mobility with increased chemosensitivity of glioblastoma cells under hypoxia. However, activation of autophagy was able to counteract these effects of miR‑224‑3p. Furthermore, in vivo experiments indicated that the miR‑224‑3p mimic enhanced the chemosensitivity of LN229 cells to temozolomide by immunohistochemistry and TUNEL assay. In summary, our experiments elucidated that the HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced autophagy in glioblastoma and astrocytoma. Therefore, miR‑224‑3p could be a novel target against hypoxia‑induced autophagy in glioblastoma and astrocytoma.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30569180     DOI: 10.3892/or.2018.6929

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  20 in total

1.  Molecular docking, synthesis, and biological evaluation of 7-azaindole-derivative (7AID) as novel anti-cancer agent and potent DDX3 inhibitor:-an in silico and in vitro approach.

Authors:  Ravinder Doneti; Akbar Pasha; Mahendran Botlagunta; S K Heena; Veera Venkata Vara Prasad Mutyala; Smita C Pawar
Journal:  Med Oncol       Date:  2022-09-01       Impact factor: 3.738

2.  MALAT1 affects hypoxia-induced vascular endothelial cell injury and autophagy by regulating miR-19b-3p/HIF-1α axis.

Authors:  Huzi Liu; Chunli Shi; Yongzhi Deng
Journal:  Mol Cell Biochem       Date:  2020-01-13       Impact factor: 3.842

3.  Hypoxia-Induced Autophagy Degrades Stromal Lumican into Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma: A Mini-Review.

Authors:  Bhaswati Sarcar; Xinqun Li; Jason B Fleming
Journal:  J Cancer Treatment Diagn       Date:  2019-02-22

Review 4.  Role of non-coding RNAs and RNA modifiers in cancer therapy resistance.

Authors:  Xinyi Zhang; Kai Xie; Honghua Zhou; Yuwei Wu; Chan Li; Yating Liu; Zhaoya Liu; Qian Xu; Shuang Liu; Desheng Xiao; Yongguang Tao
Journal:  Mol Cancer       Date:  2020-03-02       Impact factor: 27.401

Review 5.  The interplay between HIF-1α and noncoding RNAs in cancer.

Authors:  Xiafeng Peng; Han Gao; Rui Xu; Huiyu Wang; Jie Mei; Chaoying Liu
Journal:  J Exp Clin Cancer Res       Date:  2020-02-03

Review 6.  Oxygen-Based Nanocarriers to Modulate Tumor Hypoxia for Ameliorated Anti-Tumor Therapy: Fabrications, Properties, and Future Directions.

Authors:  Xianqiang Li; Yue Wu; Rui Zhang; Wei Bai; Tiantian Ye; Shujun Wang
Journal:  Front Mol Biosci       Date:  2021-07-01

Review 7.  Autophagy in cancers including brain tumors: role of MicroRNAs.

Authors:  Mohammad Hossein Pourhanifeh; Maryam Mahjoubin-Tehran; Mohammad Reza Karimzadeh; Hamid Reza Mirzaei; Zahra Sadat Razavi; Amirhossein Sahebkar; Nayyerehsadat Hosseini; Hamed Mirzaei; Michael R Hamblin
Journal:  Cell Commun Signal       Date:  2020-06-09       Impact factor: 5.712

Review 8.  MicroRNA-Based Combinatorial Cancer Therapy: Effects of MicroRNAs on the Efficacy of Anti-Cancer Therapies.

Authors:  Hyun Ah Seo; Sokviseth Moeng; Seokmin Sim; Hyo Jeong Kuh; Soo Young Choi; Jong Kook Park
Journal:  Cells       Date:  2019-12-20       Impact factor: 6.600

Review 9.  Autophagy Takes Center Stage as a Possible Cancer Hallmark.

Authors:  Jose G Alvarez-Meythaler; Yoelsis Garcia-Mayea; Cristina Mir; Hiroshi Kondoh; Matilde E LLeonart
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

Review 10.  Molecular and Cellular Complexity of Glioma. Focus on Tumour Microenvironment and the Use of Molecular and Imaging Biomarkers to Overcome Treatment Resistance.

Authors:  Silvia Valtorta; Daniela Salvatore; Paolo Rainone; Sara Belloli; Gloria Bertoli; Rosa Maria Moresco
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.